Filing Details
- Accession Number:
- 0001104659-24-108768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-15 20:11:24
- Reporting Period:
- 2024-10-14
- Accepted Time:
- 2024-10-15 20:11:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1819576 | Liquidia Corp | LQDA | Pharmaceutical Preparations (2834) | 851710962 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1935638 | Rajeev Saggar | 419 Davis Drive, Suite 100 Morrisville NC 27560 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-10-14 | 2,260 | $11.11 | 207,383 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
- These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 11, 2023.
- Includes (i) 23,458 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 46,874 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 56,492 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iv) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.